I did read it. They call it a "product" and later a "medication".
If I'm not mistaken they only recently finished a phase 2a trial of 6 weeks, but I have not seen a phase 3 trial and regulator approval necessary for it to be called a medicine. If I'm mistaken about the process, mea culpa. This is why I ask.
If it's not medicine I wonder if the price they want to sell for is not high for a supplement, but I admit I don't know that specific market at all.
CannEpil™ — The first product from MGC Pharma, page-7
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.94M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2800 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 101 | 1 |
View Market Depth
| Last trade - 07.10am 04/06/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable